FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q80967322> ?p ?o ?g. }

• Q80967322 description "artikull shkencor i botuar më 01 janar 1998" @default.
• Q80967322 description "artículu científicu espublizáu en xineru de 1998" @default.
• Q80967322 description "im Jahr 1998 veröffentlichter wissenschaftlicher Artikel" @default.
• Q80967322 description "scientific article published on 01 January 1998" @default.
• Q80967322 description "wetenschappelijk artikel" @default.
• Q80967322 description "наукова стаття, опублікована в січні 1998" @default.
• Q80967322 name "Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome" @default.
• Q80967322 name "Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome" @default.
• Q80967322 name "Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome" @default.
• Q80967322 type Item @default.
• Q80967322 label "Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome" @default.
• Q80967322 label "Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome" @default.
• Q80967322 label "Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome" @default.
• Q80967322 prefLabel "Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome" @default.
• Q80967322 prefLabel "Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome" @default.
• Q80967322 prefLabel "Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome" @default.
• Q80967322 P1433 Q80967322-F1F81F7A-6A5D-41F0-B517-65D79980A393 @default.
• Q80967322 P1476 Q80967322-8BD226C4-C6CD-4980-9B35-BF32167A8453 @default.
• Q80967322 P2093 Q80967322-2E3C92C7-8CEA-4E4C-8D2B-6EA50066B549 @default.
• Q80967322 P2093 Q80967322-B1933832-5C98-41E9-B74C-6AC2BFBF9D3A @default.
• Q80967322 P2093 Q80967322-EE408037-F0CE-45FB-AC93-400331BC7880 @default.
• Q80967322 P2860 Q80967322-02EBBC0E-C052-47EB-AA98-611BF119C8D3 @default.
• Q80967322 P2860 Q80967322-0355A283-D844-4B5C-838E-8B725C719547 @default.
• Q80967322 P2860 Q80967322-0787132F-B6B5-40D3-9393-AEBBD98D0DFB @default.
• Q80967322 P2860 Q80967322-1B6B21CE-FB45-495E-827A-D394DE29A836 @default.
• Q80967322 P2860 Q80967322-1FB4A9F3-3143-4F94-9AC4-11259F785969 @default.
• Q80967322 P2860 Q80967322-202501F4-4784-4CEC-A84E-A82F7AA2DC71 @default.
• Q80967322 P2860 Q80967322-203661CA-9EF9-46FF-8610-F0B701C77827 @default.
• Q80967322 P2860 Q80967322-21DE2E07-E2EE-409C-8AA8-6BF4F5381E79 @default.
• Q80967322 P2860 Q80967322-33D3C934-2F18-485C-AC04-2B89F7A713FC @default.
• Q80967322 P2860 Q80967322-34AA5AEC-7AC3-454F-B51E-C87CEEF4A6DF @default.
• Q80967322 P2860 Q80967322-42371544-1C0C-4407-9559-03E0340D758B @default.
• Q80967322 P2860 Q80967322-51013F37-0073-4E97-A733-4317946B51FA @default.
• Q80967322 P2860 Q80967322-5235A254-C124-44D1-9F57-9ED968720A32 @default.
• Q80967322 P2860 Q80967322-598DAC51-ACDF-4D57-8418-8C959FA433DD @default.
• Q80967322 P2860 Q80967322-5C81996A-3979-40AD-AE92-426632444D8B @default.
• Q80967322 P2860 Q80967322-62D4E37B-F151-4449-947C-CD8393A8FF60 @default.
• Q80967322 P2860 Q80967322-6FC6576B-E00A-4CDD-95B5-B66D1C04A4B5 @default.
• Q80967322 P2860 Q80967322-7D639B98-0A8D-42FC-9CAB-45A2195230B1 @default.
• Q80967322 P2860 Q80967322-84867D46-71D0-43D3-871E-326378BF505F @default.
• Q80967322 P2860 Q80967322-926E6140-46E6-4750-BFF8-1FF627289A84 @default.
• Q80967322 P2860 Q80967322-9B911F99-2B5A-40EB-AEC7-CBCF7A1164D0 @default.
• Q80967322 P2860 Q80967322-B681C7D5-A11C-45A2-A0FA-98AA4E7CB6D0 @default.
• Q80967322 P2860 Q80967322-BDEB099C-01F3-43B0-ADBE-E13716AA195E @default.
• Q80967322 P2860 Q80967322-C17AFE86-960E-40A2-B3A9-5B9F24B0784A @default.
• Q80967322 P2860 Q80967322-D353513D-CC05-4571-A291-6A7072293C85 @default.
• Q80967322 P2860 Q80967322-D554163B-6445-463D-80D2-553FFF07DDE9 @default.
• Q80967322 P2860 Q80967322-E2BF47B8-BC8C-4D47-9304-41298FF36609 @default.
• Q80967322 P2860 Q80967322-FB304CBC-D05D-4C55-9F57-58C7A8A90EF2 @default.
• Q80967322 P304 Q80967322-A72C3665-FD62-4D50-80E5-094FA807D981 @default.
• Q80967322 P31 Q80967322-A1C73CAA-F0C1-4A0B-A715-9C58104BEC72 @default.
• Q80967322 P356 Q80967322-BA87ECD1-6646-4578-A8A8-05642EB0406D @default.
• Q80967322 P433 Q80967322-1EC7CA11-EC7B-473A-A4E2-C1FD68BA098A @default.
• Q80967322 P478 Q80967322-1AC0B609-5F92-4E15-A99D-91E3B1DB3A98 @default.
• Q80967322 P50 Q80967322-2A3F2CF4-AAA6-41FD-BA01-C8766931931A @default.
• Q80967322 P577 Q80967322-EA6C94D3-4017-49EA-8E70-0B0FF3D22847 @default.
• Q80967322 P698 Q80967322-397F2303-1B8C-475B-9B01-CF844485854F @default.
• Q80967322 P921 Q80967322-3E174483-1250-41AD-AB39-E8817C553A91 @default.
• Q80967322 P921 Q80967322-E983A05F-7FEF-4847-A9F7-95C5E7290D08 @default.
• Q80967322 P356 00044011-199816030-00005 @default.
• Q80967322 P698 18370542 @default.
• Q80967322 P1433 Q15753215 @default.
• Q80967322 P1476 "Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome" @default.
• Q80967322 P2093 "A Satta" @default.
• Q80967322 P2093 "E Bartoli" @default.
• Q80967322 P2093 "R Faedda" @default.
• Q80967322 P2860 Q28335303 @default.
• Q80967322 P2860 Q34682963 @default.
• Q80967322 P2860 Q36761035 @default.
• Q80967322 P2860 Q38143864 @default.
• Q80967322 P2860 Q39520531 @default.
• Q80967322 P2860 Q39652278 @default.
• Q80967322 P2860 Q40370025 @default.
• Q80967322 P2860 Q43622090 @default.
• Q80967322 P2860 Q53452950 @default.
• Q80967322 P2860 Q53724501 @default.
• Q80967322 P2860 Q53837272 @default.
• Q80967322 P2860 Q54217230 @default.
• Q80967322 P2860 Q54609403 @default.
• Q80967322 P2860 Q57704416 @default.
• Q80967322 P2860 Q64912322 @default.
• Q80967322 P2860 Q67647462 @default.
• Q80967322 P2860 Q70174125 @default.
• Q80967322 P2860 Q70594857 @default.
• Q80967322 P2860 Q70704481 @default.
• Q80967322 P2860 Q71087118 @default.
• Q80967322 P2860 Q71147429 @default.
• Q80967322 P2860 Q71289732 @default.
• Q80967322 P2860 Q71752287 @default.
• Q80967322 P2860 Q72081327 @default.
• Q80967322 P2860 Q72111147 @default.
• Q80967322 P2860 Q72752999 @default.
• Q80967322 P2860 Q72849010 @default.
• Q80967322 P2860 Q74462467 @default.
• Q80967322 P304 "211-218" @default.
• Q80967322 P31 Q13442814 @default.
• Q80967322 P356 "10.2165/00044011-199816030-00005" @default.
• Q80967322 P433 "3" @default.
• Q80967322 P478 "16" @default.
• Q80967322 P50 Q53754880 @default.

• next